If you register now, then you can choose to watch it live or later. The webinar will be available later, but without any CME points.

>LIVE:  16 January 2027, Saturday 10:00 am (UK time zone)

Agenda

• 40 minutes presentation and then 20 minutes Q&A with the host Nathan Nagel
• Understanding triple and multi-agonist incretin mechanisms
• Reviewing clinical data from early-phase studies

• • Evaluating efficacy trends and safety considerations

  • Exploring ethical issues in early clinical adoption

  • Anticipating NHS guidance and formulary positioning

  • Preparing for changes in primary care prescribing

  • Considering future service delivery models